Cargando…

Action Sites and Clinical Application of HIF-1α Inhibitors

Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Renfeng, Wang, Fan, Yang, Hongqin, Wang, Zhengchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182161/
https://www.ncbi.nlm.nih.gov/pubmed/35684364
http://dx.doi.org/10.3390/molecules27113426
_version_ 1784723966699503616
author Xu, Renfeng
Wang, Fan
Yang, Hongqin
Wang, Zhengchao
author_facet Xu, Renfeng
Wang, Fan
Yang, Hongqin
Wang, Zhengchao
author_sort Xu, Renfeng
collection PubMed
description Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases.
format Online
Article
Text
id pubmed-9182161
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91821612022-06-10 Action Sites and Clinical Application of HIF-1α Inhibitors Xu, Renfeng Wang, Fan Yang, Hongqin Wang, Zhengchao Molecules Review Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form different signaling pathways with various upstream and downstream proteins, mediate hypoxia signals, regulate cells to produce a series of compensatory responses to hypoxia, and play an important role in the physiological and pathological processes of the body, so it is a focus of biomedical research. In recent years, various types of HIF-1α inhibitors have been designed and synthesized and are expected to become a new class of drugs for the treatment of diseases such as tumors, leukemia, diabetes, and ischemic diseases. This article mainly reviews the structure and functional regulation of HIF-1α, the modes of action of HIF-1α inhibitors, and the application of HIF-1α inhibitors during the treatment of diseases. MDPI 2022-05-26 /pmc/articles/PMC9182161/ /pubmed/35684364 http://dx.doi.org/10.3390/molecules27113426 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Xu, Renfeng
Wang, Fan
Yang, Hongqin
Wang, Zhengchao
Action Sites and Clinical Application of HIF-1α Inhibitors
title Action Sites and Clinical Application of HIF-1α Inhibitors
title_full Action Sites and Clinical Application of HIF-1α Inhibitors
title_fullStr Action Sites and Clinical Application of HIF-1α Inhibitors
title_full_unstemmed Action Sites and Clinical Application of HIF-1α Inhibitors
title_short Action Sites and Clinical Application of HIF-1α Inhibitors
title_sort action sites and clinical application of hif-1α inhibitors
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9182161/
https://www.ncbi.nlm.nih.gov/pubmed/35684364
http://dx.doi.org/10.3390/molecules27113426
work_keys_str_mv AT xurenfeng actionsitesandclinicalapplicationofhif1ainhibitors
AT wangfan actionsitesandclinicalapplicationofhif1ainhibitors
AT yanghongqin actionsitesandclinicalapplicationofhif1ainhibitors
AT wangzhengchao actionsitesandclinicalapplicationofhif1ainhibitors